Market Overview

The Global Whole Exome Sequencing Market was valued at USD 2,226.3 million in 2023 and is expected to reach USD 8,540.0 million by 2031 while growing at a CAGR of 18.3% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global whole exome sequencing market growth. Whole exome sequencing (WES) is a high-throughput genomic technology used to analyze the protein-coding regions of an individual's genome, known as the exome, which constitutes only 1-2% of the human genome but harbors around 85% of disease-causing mutations. WES enables comprehensive sequencing and analysis of all exons, offering crucial insights into genetic variations and their links to diseases or traits.

The continuous evolution of next-generation sequencing (NGS) technologies, bioinformatics algorithms, and data analysis pipelines, coupled with the increasing demand for precision medicine, propels the whole exome sequencing (WES) market forward. Nonetheless, obstacles such as intricate data analysis and interpretation, along with ethical and privacy concerns, impede its growth.

Furthermore, the global whole exome sequencing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Technology Analysis

The Global Whole Exome Sequencing Market is segmented among Sequencing by Synthesis, Ion Semiconductor Sequencing, and Others, based on Technology. In 2023, Ion Semiconductor Sequencing accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Product and Services Analysis

The Global Whole Exome Sequencing Market is segmented among Second-Generation Sequencing, and Third-Generation Sequencing, based on Product and Services. In 2023, XX accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Whole Exome Sequencing Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are KONICA MINOLTA, INC. (Ambry Genetics), Beijing Genomics Institute, Bio-Rad Laboratories Inc., Eurofins Scientific Group, F. Hoffmann-La Roche AG, Azenta, Inc., Illumina Inc., Psomagen, Inc (Macrogen Inc.), PerkinElmer Inc., and Thermo Fisher Scientific Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Whole Exome Sequencing Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Whole Exome Sequencing Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Whole Exome Sequencing Market Segmentation, By Technology

• Global Whole Exome Sequencing Market Share Analysis, By Technology

• Global Whole Exome Sequencing Market Growth Analysis, By Technology

• Global Whole Exome Sequencing Market Trends, By Technology

o Sequencing by Synthesis

o Ion Semiconductor Sequencing

o Others

6. Global Whole Exome Sequencing Market Segmentation, By Product and Services

• Global Whole Exome Sequencing Market Share Analysis, By Product and Services

• Global Whole Exome Sequencing Market Growth Analysis, By Product and Services

• Global Whole Exome Sequencing Market Trends, By Product and Services

o Products

o Systems

o Kits

o Service Sequencing Services

o Data Analysis Services

o Others

7. Global Whole Exome Sequencing Market Segmentation, By Application

• Global Whole Exome Sequencing Market Share Analysis, By Application

• Global Whole Exome Sequencing Market Growth Analysis, By Application

• Global Whole Exome Sequencing Market Trends, By Application

o Diagnostics

o Cancer

o Monogenic Disorders

o Diabetes

o Others

o Drug Discovery and Development

o Personalized Medicine

o Others

8. Global Whole Exome Sequencing Market Segmentation, By End Users

• Global Whole Exome Sequencing Market Share Analysis, By End Users

• Global Whole Exome Sequencing Market Growth Analysis, By End Users

• Global Whole Exome Sequencing Market Trends, By End Users

o Research Center, Academic and Government Institutions

o Hospitals and Clinics

o Pharmaceuticals and Biotechnology Companies

o Others

9. Global Whole Exome Sequencing Market Segmentation, By Region

• Global Whole Exome Sequencing Market Share Analysis, By Region

• Global Whole Exome Sequencing Market Growth Analysis, By Region

• Global Whole Exome Sequencing Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

10. Competitive Landscape

• KONICA MINOLTA, INC. (Ambry Genetics) *

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Beijing Genomics Institute

• Bio-Rad Laboratories Inc.

• Eurofins Scientific Group

• F. Hoffmann-La Roche AG

• Azenta, Inc.

• Illumina Inc.

• Psomagen, Inc (Macrogen Inc.)

• PerkinElmer Inc.

• Thermo Fisher Scientific Inc.

*Similar analysis will be provided for each company listed above.